IL283840A
(en )
2021-07-29
Compositions for the delivery of therapeutic agents and methods of use and making thereof
UA45271S
(en )
2022-09-15
DEVICE FOR DELIVERY OF NICOTINE CONTAINING POWDER INTO THE SMOKER'S BODY
IL272308A
(en )
2020-03-31
Use of inhaled nitric oxide for the improvement of right and/or left ventricular function
SG11202009574RA
(en )
2020-10-29
Combinations of osteopontin and 2'-fucosyllactose for use as medicaments
UA44294S
(en )
2021-09-02
1.-3. DEVICE FOR FORMATION OF AEROSOL FOR DELIVERY OF NICOTINE-CONTAINING AEROSOL TO USER'S BODY; 4. A BUTTON FOR AN AEROSOL DEVICE FOR DELIVERING A NICOTINE-CONTAINING AEROSOL TO THE USER'S BODY; 5. CAP FOR AN AEROSOL DEVICE FOR DELIVERING A NICOTINE-CONTAINING AEROSOL TO THE USER'S BODY
MA52253A
(en )
2021-02-17
NASAL POWDER FORMULATION FOR THE TREATMENT OF HYPOGLYCEMIA
IL266519A
(en )
2019-07-31
Pharmaceutical use of an extended-release composition containing pirfenidone for the treatment and reversal of human steatohepatitis (nafld/nash
ZA202104378B
(en )
2022-07-27
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
GB2582683B
(en )
2022-02-23
Composition for the care of human hair
ZA201903828B
(en )
2023-02-22
Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases
UA42016S
(en )
2020-08-10
COMPONENT PART OF UNIT FOR DELIVERY OF NICOTINE CONTAINING POWDER IN THE USER'S BODY
PL3937949T3
(en )
2024-04-22
Phytoecdysones and the derivatives thereof for use in the treatment of impaired lung function
EP3758688C0
(en )
2024-03-27
Nk-1 antagonists for use in the treatment of ocular pain
IL268549B
(en )
2021-10-31
1-(4-amino-5-bromo-6-(1 h-pyrazol-1-yl)pyrimidin-2-yl)-1 h-pyrazol-4-ol and use thereof in the treatment of cancer
EP3796951A4
(en )
2021-07-07
Foam formulations and delivery methods to the body
UA44137S
(en )
2021-07-29
UNIT FOR DELIVERY OF NICOTINE-CONTAINING POWDER TO THE SMOKER'S BODY
EP3565636C0
(en )
2024-01-03
Use of gut microbiota in the diagnosis of parkinson's disease
IL282142A
(en )
2021-05-31
4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
IL283315A
(en )
2021-07-29
Heterocyclic compounds and medical use thereof
GB201817346D0
(en )
2018-12-12
Compounds and pharmaceutical compositions thereof for use in the treatment of diseases
GB201612786D0
(en )
2016-09-07
Apparatus for use in the care of a person's body
EP3612188A4
(en )
2021-02-24
Heterobivalent ligands suitable for use in the treatment of parkinson's disease
HK1257288A1
(en )
2019-10-18
Use of inhibitors of the activity or function of pi3k for the treatment of primary sjögren's syndrome
EP3749234C0
(en )
2023-11-29
Medical device for the delivery of therapeutic formulations
TWD183946S
(en )
2017-07-01
protective gear